1-2 of 2
Pansy Minnick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical pharmacology strategies to support dose optimization of the recommended Phase 2 dose regimen of JNJ-5322, a BCMA×GPRC5D×CD3 trispecific antibody, in Relapsed/Refractory multiple myeloma

Free
Ashley Nguyen, Jie Zhou, Thomas Prior, Joseph Weidman, Sangmin Lee, Pansy Minnick, Daniel Jonathan, Caroline Hodin, Brandi Hilder, Nikki Daskalakis, Mahesh Samtani, Nahor Haddish-Berhane, Indrajeet Singh
Journal: Blood
Blood (2025) 146 (Supplement 1): 4054.
https://doi.org/10.1182/blood-2025-4054
Published: 2025
Journal Articles

Updated efficacy and safety results of JNJ-5322, a novel, next-generation BCMA×GPRC5D×CD3 trispecific antibody, in patients with Relapsed/Refractory multiple myeloma

Free
Amrita Krishnan, Martin Kaiser, Rakesh Popat, Jeffrey Matous, Alfred Garfall, Gala Vega, Aurore Perrot, Sébastien Anguille, Albert Oriol, Nicolas Kint, Jo Caers, Saad Usmani, Lionel Karlin, Larysa Sanchez, Cindy Varga, Wilfried Roeloffzen, Laura Rosiñol Dachs, Darren Pan, Paula Rodriguez-Otero, María-Victoria Mateos, Tadao Ishida, Kentaro Fukushima, Pansy Minnick, M. Damiette Smit, Nikki Daskalakis, Thomas Prior, Deeksha Vishwamitra, Emily DeSantis, Ashley Nguyen, Brandi Hilder, Joseph Weidman, Caroline Hodin, Daniel Jonathan, Sangmin Lee, Cyrille Touzeau, Hans Lee, Niels W.C.J. Van De Donk, Monique Minnema
Journal: Blood
Blood (2025) 146 (Supplement 1): 4042.
https://doi.org/10.1182/blood-2025-4042
Published: 2025